Astellas Pharma is focusing on diversification, with its portfolio spanning cancer, vision loss and menopause treatments. Its Chief Medical Officer, Tadaaki Taniguci, said the company was also expanding its gene therapy output, using acquisitions and licensing to build capability, while in oncology, the firm’s lead drugs include treatments for prostate and bladder cancer. Astellas is also testing a small molecule for treating menopause symptoms.
Fake Reddit sites found pushing Lumma Stealer malware
Cybersecurity researchers from Sekoia have warned of hundreds of fake Reddit and WeTransfer pages used to deploy the Lumma Stealer malware. The well-built fake Reddit
